Skip to main content

Chitosan/Polylactic Acid/Tripolyphosphate Nanocapsules for Encapsulation of Water-Insoluble Drugs: In vitro Drug Release and Cytotoxicity

Buy Article:

$107.14 + tax (Refund Policy)

Much attention has been paid to chitosan-based nanoparticles for drug and gene delivery. In this study, chitosan/polylactic acid/tripolyphosphate (CS/PLA/TPP) nanoparticles were successfully prepared for encapsulation of insoluble drugs, which was confirmed by Fourier transform infrared spectroscopy (FTIR). The nanoparticles were regular, spherical and had a uniform diameter of around 300 nm. The entrapment efficiency of the obtained CS/PLA/TPP nanoparticles for azithromycin (AZI) varied with both the ratio of CS to PLA and the ratio of CS to AZI. The highest entrapment efficiency above 85% was realized, with 4:1 ratio for CS:PLA and 10:13 ratio for CS:AZI. A sustained and controlled in vitro drug release was also observed. Moreover, the CS/PLA/TPP nanoparticles showed little cytotoxicity when co-cultured with Hela and HEK293T cells. Though the CS/PLA/TPP nanoparticles are suitable for most water-insoluble drugs, the entrapment capacity for different drugs varies.

Keywords: AZITHROMYCIN; CHITOSAN; ENTRAPMENT EFFICIENCY; POLYLACTIC ACID

Document Type: Research Article

Publication date: 01 December 2013

More about this publication?
  • Science of Advanced Materials (SAM) is an interdisciplinary peer-reviewed journal consolidating research activities in all aspects of advanced materials in the fields of science, engineering and medicine into a single and unique reference source. SAM provides the means for materials scientists, chemists, physicists, biologists, engineers, ceramicists, metallurgists, theoreticians and technocrats to publish original research articles as reviews with author's photo and short biography, full research articles and communications of important new scientific and technological findings, encompassing the fundamental and applied research in all latest aspects of advanced materials.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content